The money will go to genome sequencing, research centers for genomic epidemiology and the national bioinformatics network.
The United States will invest $ 1.7 billion to help states and the US Centers for Disease Control and Prevention fight the COVID-19 variants that are spreading rapidly across the United States.
The White House says the investment is part of President Joe Biden’s $ 1.9 trillion “American Rescue Plan” and will improve the detection, monitoring and mitigation of variations. This is by expanding genome sequencing efforts, the White House said on Friday.
“The original strain of COVID-19 accounts for only about half of all cases in America today. The White House said in a statement there were new and potentially dangerous strains of the virus that made up the other half.
In early February, US laboratories sequenced approximately 8,000 strains of COVID-19 per week. Since then, the administration has invested nearly $ 200 million to increase Gene sequencing to 29,000 samples per week – an effort that will be fueled by new funding.
The investment will be divided into three areas: $ 1 billion to expand the genome sequence, $ 400 million to help build six research centers for genomic epidemiology and 300 million dollars to build the national bioinformatics infrastructure – that will help build a data warehouse.
The first funding portion will be distributed in early May and the next round will be invested over the next few years, the White House said.
The White House provided a state-by-state budget analysis with California getting $ 17 million, Texas getting $ 15 million, and Florida $ 12 million.
A White House official said on Thursday that the United States is preparing for possibility a booster shot will be needed nine to 12 months after people first get the COVID-19 vaccine.
Pfizer Inc chief executive Albert Bourla says people are “likely” to need a third booster dose of COVID-19 within 12 months and may need a yearly vaccination.
The United States provided 198,317,040 doses of the COVID-19 vaccine nationwide as of Thursday morning and has delivered 255,400,665 doses, according to the CDC.